From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model
BioProcessing Journal · 27.07.2026 · 3
DOI: 10.12665/j121.carson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
Consistent with our well-established format, this issue contains a very interesting collection of technical articles. However, we have stepped outside our normal content with a manuscript on the successful implementation of a “spin-out” company that was formed to develop a highly specialized technology. I’m hoping that this article by Dr. Charlotte Dyring (ExpreS2ion Biotechnologies) will provide inspiration to others who have envisioned a similar business model, plus trace a roadmap for organizations which have discovered that mergers and acquisitions aren’t giving them the products or sustainable growth they really need...
Zitieren
APA
Carson, K. L. (2026). From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model. BioProcessing Journal, 3. https://doi.org/10.12665/j121.carson
Vancouver
Carson KL. From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model. BioProcessing Journal. 2026:3. doi:10.12665/j121.carson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model},
journal = {BioProcessing Journal},
year = {2026},
pages = {3},
doi = {10.12665/j121.carson}
}
EUVIMED